Aiming for Study Comparability in Parkinson's Disease: Proposal for a Modular Set of Biomarker Assessments to be Used in Longitudinal Studies.
Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of TuebingenTuebingen, Germany; German Center for Neurodegenerative Diseases, University of TuebingenTuebingen, Germany.
Stefanie
S
Lerche
Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of TuebingenTuebingen, Germany; German Center for Neurodegenerative Diseases, University of TuebingenTuebingen, Germany.
Sebastian
S
Heinzel
Norwegian Centre for Movement Disorders, Stavanger University Hospital Stavanger, Norway.
Guido W
GW
Alves
Neuroscience Section, Center for Neurodegenerative Diseases (CEMAND), Department of Medicine and Surgery, University of Salerno Salerno, Italy.
Paolo
P
Barone
Department of Neurology, Saarland University Hospital Homburg, Germany.
Stefanie
S
Behnke
School of Social and Community Medicine, University of Bristol Bristol, UK.
Yoav
Y
Ben-Shlomo
Department of Neurology and Neuroscience Campus Amsterdam, VU University Hospital Amsterdam, Netherlands.
Henk
H
Berendse
Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition, and Behavior Nijmegen, Netherlands.
Bastiaan R
BR
Bloem
Institute of Neuroscience, Newcastle University Newcastle, UK.
David
D
Burn
Department of Neurology, Philipps-Universität Marburg Marburg, Germany.
Richard
R
Dodel
Institute of Neurological Sciences, Queen Elizabeth University Hospital Glasgow, UK.
Donald G
DG
Grosset
Clinical and Experimental Neuroscience, Luxembourg Centre for Systems Biomedicine, University of LuxembourgBelval, Luxembourg; Centre Hospitalier LuxembourgLuxembourg, Luxembourg.
Geraldine
G
Hipp
Nuffield Department of Clinical Neurosciences, Oxford Parkinson's Disease Centre, University of Oxford Oxford, UK.
Michele T
MT
Hu
Institute of Neurogenetics, University of Lübeck Lübeck, Germany.
Meike
M
Kasten
Clinical and Experimental Neuroscience, Luxembourg Centre for Systems Biomedicine, University of LuxembourgBelval, Luxembourg; Centre Hospitalier LuxembourgLuxembourg, Luxembourg.
Rejko
R
Krüger
Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of TuebingenTuebingen, Germany; German Center for Neurodegenerative Diseases, University of TuebingenTuebingen, Germany.
Inga
I
Liepelt-Scarfone
Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of TuebingenTuebingen, Germany; German Center for Neurodegenerative Diseases, University of TuebingenTuebingen, Germany.
Walter
W
Maetzler
Neuroscience Section, Center for Neurodegenerative Diseases (CEMAND), Department of Medicine and Surgery, University of Salerno Salerno, Italy.
Marcello
M
Moccia
Paracelsus-Elena-KlinikKassel, Germany; University Medical Center, Georg-August-Universität GöttingenGöttingen, Germany.
Brit
B
Mollenhauer
Department of Neurology, Philipps-Universität Marburg Marburg, Germany.
Wolfgang
W
Oertel
Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of TuebingenTuebingen, Germany; German Center for Neurodegenerative Diseases, University of TuebingenTuebingen, Germany.
Benjamin
B
Roeben
Department of Neurology, University of Rostock Rostock, Germany.
Uwe
U
Walter
Department of Epidemiology and Biostatistics, Karolinska InstitutetStockholm, Sweden; Department of Clinical Neuroscience, Karolinska InstitutetStockholm, Sweden.
Karin
K
Wirdefeldt
Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of TuebingenTuebingen, Germany; German Center for Neurodegenerative Diseases, University of TuebingenTuebingen, Germany; Department of Neurology, Christian-Albrechts UniversityKiel, Germany.
Daniela
D
Berg
Parkinson's disease; cohort studies; harmonization; marker